title: Animal models of the serotonin syndrome: a systematic review.
abstract: The serotonin syndrome (SS) is a potentially life-threatening disorder in humans which is induced by ingestion of an overdose or by combination of two or more serotonin (5-HT)-enhancing drugs. In animals, acute administration of direct and indirect 5-HT agonists also leads to a set of behavioral and autonomic responses. In the current review, we provide an overview of the existing versions of the animal model of the SS. With a focus on studies in rats and mice, we analyze the frequency of behavioral and autonomic responses following administration of 5-HT-enhancing drugs and direct 5-HT agonists administered alone or in combination, and we briefly discuss the receptor mediation of these responses. Considering species differences, we identify a distinct set of behavioral and autonomic responses that are consistently observed following administration of direct and indirect 5-HT agonists. Finally, we discuss the importance of a standardized assessment of SS responses in rodents and the utility of animal models of the SS in translational studies, and provide suggestions for future research.
authors.affiliation: Institute of Pharmacology and Toxicology, School of Veterinary Medicine, Freie Universität Berlin, Koserstrasse 20, 14195 Berlin, Germany.
authors.forename: Robert
authors.initials: R
authors.lastname: Haberzettl
authors.forename: Bettina
authors.initials: B
authors.lastname: Bert
authors.forename: Heidrun
authors.initials: H
authors.lastname: Fink
authors.forename: Meredith A
authors.initials: MA
authors.lastname: Fox
mesh_terms: D000818:Animals; D004195:Disease Models, Animal; D006801:Humans; D051379:Mice; D051381:Rats; D018490:Serotonin Agents / Q000009:adverse effects; D020230:Serotonin Syndrome / Q000175:diagnosis / Q000503:physiopathology*
chemical_list: D018490:Serotonin Agents
keywords: 5-HT; 5-HT agonist; 5-HT transporter; 5-HT-enhancing drug; 5-HTP; 5-HTT; 5-hydroxy-l-tryptophan; Animal model; Core response; MAO; MAOA-I; MAOA/B-I; MAOB-I; Mouse; Rat; SNRI; SRI; SS; SSRI; Serotonin; Serotonin syndrome; TCA; Validity; monoamine oxidase; monoamine oxidase type A inhibitor; monoamine oxidase type A/B inhibitor; selective serotonin reuptake inhibitor; serotonin; serotonin reuptake inhibitor; serotonin syndrome; serotonin/norepinephrine reuptake inhibitor; tricyclic antidepressant